Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs1860661
rs1860661
TCF3
0.810 GeneticVariation BEFREE We identify a novel variant at 19p13.3 associated with HL (rs1860661; odds ratio (OR)=0.81, 95% confidence interval (95% CI) = 0.76-0.86, P(combined) = 3.5 × 10(-10)), located in intron 2 of TCF3 (also known as E2A), a regulator of B- and T-cell lineage commitment known to be involved in HL pathogenesis. 24920014

2014
dbSNP: rs1860661
rs1860661
TCF3
0.810 GeneticVariation GWASDB We identify a novel variant at 19p13.3 associated with HL (rs1860661; odds ratio (OR)=0.81, 95% confidence interval (95% CI) = 0.76-0.86, P(combined) = 3.5 × 10(-10)), located in intron 2 of TCF3 (also known as E2A), a regulator of B- and T-cell lineage commitment known to be involved in HL pathogenesis. 24920014

2014
dbSNP: rs1860661
rs1860661
TCF3
0.810 GeneticVariation GWASCAT We identify a novel variant at 19p13.3 associated with HL (rs1860661; odds ratio (OR)=0.81, 95% confidence interval (95% CI) = 0.76-0.86, P(combined) = 3.5 × 10(-10)), located in intron 2 of TCF3 (also known as E2A), a regulator of B- and T-cell lineage commitment known to be involved in HL pathogenesis. 24920014

2014
dbSNP: rs20541
rs20541
IL13 ; TH2LCRR
A 0.810 GeneticVariation GWASDB A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus. 24920014

2014
dbSNP: rs20541
rs20541
IL13 ; TH2LCRR
0.810 GeneticVariation BEFREE We searched for an association between the interleukin 4 receptor gene (IL4R) rs1805015 and interleukin 13 gene (IL13) rs20541 polymorphisms and the development of antibodies to hepatitis B surface antigen (anti-HBs) in the case of hepatitis B virus (HBV) vaccination or infection in hemodialysis (HD) patients. 23462527

2013
dbSNP: rs20541
rs20541
IL13 ; TH2LCRR
0.810 GeneticVariation GWASDB Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups. 22286212

2012
dbSNP: rs20541
rs20541
IL13 ; TH2LCRR
0.810 GeneticVariation GWASCAT Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups. 22286212

2012
dbSNP: rs2019960
rs2019960
PVT1
C 0.800 GeneticVariation GWASCAT A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus. 24920014

2014
dbSNP: rs2019960
rs2019960
PVT1
C 0.800 GeneticVariation GWASDB A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus. 24920014

2014
dbSNP: rs2069757
rs2069757
TH2LCRR
A 0.800 GeneticVariation GWASCAT A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus. 24920014

2014
dbSNP: rs2069757
rs2069757
TH2LCRR
A 0.800 GeneticVariation GWASDB A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus. 24920014

2014
dbSNP: rs6439924
rs6439924
CLSTN2 ; LOC105374132
0.800 GeneticVariation GWASDB A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus. 24920014

2014
dbSNP: rs6439924
rs6439924
CLSTN2 ; LOC105374132
0.800 GeneticVariation GWASCAT A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus. 24920014

2014
dbSNP: rs6903608
rs6903608
HLA-DRB9
C 0.800 GeneticVariation GWASCAT A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus. 24920014

2014
dbSNP: rs6903608
rs6903608
HLA-DRB9
C 0.800 GeneticVariation GWASDB A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus. 24920014

2014
dbSNP: rs1432295
rs1432295
LINC01185
G 0.800 GeneticVariation GWASCAT Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma. 24149102

2013
dbSNP: rs1432295
rs1432295
LINC01185
G 0.800 GeneticVariation GWASDB Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma. 24149102

2013
dbSNP: rs2019960
rs2019960
PVT1
G 0.800 GeneticVariation GWASCAT Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma. 24149102

2013
dbSNP: rs2019960
rs2019960
PVT1
G 0.800 GeneticVariation GWASDB Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma. 24149102

2013
dbSNP: rs2395185
rs2395185
HLA-DRB9
C 0.800 GeneticVariation GWASDB Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma. 24149102

2013
dbSNP: rs3806624
rs3806624
EOMES
G 0.800 GeneticVariation GWASDB A combined analysis identifies new HL susceptibility loci mapping to 3p24.1 (rs3806624; P=1.14 × 10(-12), odds ratio (OR)=1.26) and 6q23.3 (rs7745098; P=3.42 × 10(-9), OR=1.21). rs3806624 localizes 5' to the EOMES (eomesodermin) gene within a p53 response element affecting p53 binding. rs7745098 maps intergenic to HBS1L and MYB, a region previously associated with haematopoiesis. 24149102

2013
dbSNP: rs3806624
rs3806624
EOMES
G 0.800 GeneticVariation GWASCAT A combined analysis identifies new HL susceptibility loci mapping to 3p24.1 (rs3806624; P=1.14 × 10(-12), odds ratio (OR)=1.26) and 6q23.3 (rs7745098; P=3.42 × 10(-9), OR=1.21). rs3806624 localizes 5' to the EOMES (eomesodermin) gene within a p53 response element affecting p53 binding. rs7745098 maps intergenic to HBS1L and MYB, a region previously associated with haematopoiesis. 24149102

2013
dbSNP: rs501764
rs501764
GATA3 ; GATA3-AS1
C 0.800 GeneticVariation GWASDB Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma. 24149102

2013
dbSNP: rs501764
rs501764
GATA3 ; GATA3-AS1
C 0.800 GeneticVariation GWASCAT Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma. 24149102

2013
dbSNP: rs6903608
rs6903608
HLA-DRB9
G 0.800 GeneticVariation GWASCAT Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma. 24149102

2013